3.8 Article

Differences in mortality rate among patients hospitalized with severe COVID-19 according to their body mass index

Related references

Note: Only part of the references are listed.
Editorial Material Medicine, General & Internal

The Obesity Paradox in Infections and Implications for COVID-19

Carl J. Lavie et al.

MAYO CLINIC PROCEEDINGS (2021)

Review Endocrinology & Metabolism

Global pandemics interconnected - obesity, impaired metabolic health and COVID-19

Norbert Stefan et al.

Summary: Obesity and impaired metabolic health are established risk factors for NCDs such as type 2 diabetes mellitus, cardiovascular disease, neurodegenerative diseases, cancer, and MAFLD, and have been linked to an increased risk of severe COVID-19. Specifically, visceral obesity and characteristics of impaired metabolic health are associated with a high risk of severe COVID-19.

NATURE REVIEWS ENDOCRINOLOGY (2021)

Article Endocrinology & Metabolism

Are overweight and obesity risk factors for invasive mechanical ventilation in severe coronavirus disease 2019 pneumonia?

Maria Fernanda Coss-Rovirosa et al.

Summary: The study showed that overweight or obese patients do not have a higher risk of requiring invasive mechanical ventilation (IMV) when using conventional BMI cutoffs, but the risk of IMV increases in patients with a BMI over 35 kg/m(2).

ARCHIVES OF ENDOCRINOLOGY METABOLISM (2021)

Article Emergency Medicine

Analysis of absolute lymphocyte count in patients with COVID-19

Zachary Illg et al.

Summary: In this study, the sensitivity of absolute lymphocyte count in patients with COVID-19 who required subsequent hospitalization was explored. Cut-off values ranged from 1.1 K/uL to 2.0 K/uL, with sensitivities of 72% and 94% respectively. Additionally, lower mean absolute lymphocyte counts were identified in males, patients requiring intubation, and patients who died.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Article Endocrinology & Metabolism

Association of obesity with postacute sequelae of COVID-19

Ali Aminian et al.

Summary: Obesity is a major risk factor for severe coronavirus disease 2019 (COVID-19) infection and mortality, and is also associated with an increased risk of developing postacute sequelae of COVID-19 (PASC).

DIABETES OBESITY & METABOLISM (2021)

Article Medicine, General & Internal

Lymphocyte blood levels that remain low can predict the death of patients with COVID-19

Hong-Jun Zhang et al.

Summary: This study aimed to investigate whether dynamic changes in lymphocyte counts can predict disease deterioration in COVID-19 patients. Results showed that low circulating lymphocyte counts were common in severe and critical COVID-19 cases.

MEDICINE (2021)

Article Multidisciplinary Sciences

Body mass index and severity/fatality from coronavirus disease 2019: A nationwide epidemiological study in Korea

In Sook Kang et al.

Summary: The study revealed a non-linear (U-shaped) relationship between BMI and fatal illness. Patients with a BMI of <18.5 kg/m(2) and those with a BMI >=25 kg/m(2) were at a higher risk of fatal illness. Maintaining a healthy weight is crucial for not only preventing chronic cardiometabolic diseases but also improving outcomes of COVID-19.

PLOS ONE (2021)

Article Endocrinology & Metabolism

Associations between body-mass index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, cohort study

Min Gao et al.

Summary: The study found that above a BMI of 23 kg/m(2), there is a linear increase in the risk of severe consequences of COVID-19 leading to hospital admission and death, and a linear increase in ICU admission risk across the entire BMI range. The impact of increasing BMI is particularly notable in individuals younger than 40 years and of Black ethnicity.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Review Medicine, Research & Experimental

Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities

Tiantian Yan et al.

Summary: Obesity is associated with higher pathogenicity of SARS-CoV-2 and worsens COVID-19 outcomes due to altered physiology, impaired immunity, cytokine storm, and thrombosis, opening possibilities for host-directed therapies in this population.

THERANOSTICS (2021)

Article Nutrition & Dietetics

Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China

Tao Li et al.

EUROPEAN JOURNAL OF CLINICAL NUTRITION (2020)

Article Endocrinology & Metabolism

Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico

Omar Yaxmehen Bello-Chavolla et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Virology

Obesity predisposes to the risk of higher mortality in young COVID-19 patients

Fengqin Zhang et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Article Medicine, General & Internal

Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide

Fabian Sanchis-Gomar et al.

MAYO CLINIC PROCEEDINGS (2020)

Article Medicine, General & Internal

Severe Covid-19

David A. Berlin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Public, Environmental & Occupational Health

Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico

Gaspar Manuel Parra-Bracamonte et al.

ANNALS OF EPIDEMIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

The obesity paradox: Analysis from the SMAtteo COvid-19 REgistry (SMACORE) cohort

Simona Biscarini et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)

Review Medicine, General & Internal

Acute Respiratory Distress Syndrome Advances in Diagnosis and Treatment

Eddy Fan et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Article Public, Environmental & Occupational Health

The utility of fat mass index vs. body mass index and percentage of body fat in the screening of metabolic syndrome

Pengju Liu et al.

BMC PUBLIC HEALTH (2013)